About us Expertise and Values
News Fresh news from our team
Solutions How we create value with our partners
Use Cases Success Stories
Insights Publications about Artificial Intelligence
Contact Us
Subscribe to our Newsletter

Tags Biotechnology

Related Solutions

Advancing Drug Discovery
Kantify has built a platform to accelerate the discovery of new drugs in silico. This next generation technology called ZeptoNet enables our pharma and biotech partners to improve target identification, hit discovery, hit optimization and ADMET optimization thanks to Artificial Intelligence. The technology has shown extremely promising results in several diseases including rare diseases.

Related Use Cases

AI in drug discovery: ADMET property prediction
Discover how artificial intelligence can help you select lead compounds that are both to be effective and do not have adverse effects on patients
Advancing Drug Discovery with Artificial Intelligence
Discover how to enhance your drug discovery pipeline using our novel Artificial Intelligence technology

Related Insights

Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Fri 19 Mar 2021
ZeptoNet White Paper: AI for drug discovery
We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale

Related News

Thu 30 Sep 2021
European Biotech Week: webinar on AI for Drug Discovery
Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021
Wed 01 Sep 2021
Kantify at the European Biotech Week: AI for Drug Discovery
Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development
Tue 24 Aug 2021
Kantify announces new upgrades on ZeptoNet
Kantify announces new upgrades on ZeptoNet - its AI technology for drug discovery
Thu 22 Jul 2021
Kantify joins the European Biotechnology Network
Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences
Mon 10 May 2021
Kantify joins Data-driven Advanced Therapeutics Accelerator
Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Wed 24 Mar 2021
European Commission Report on AI Uptake in Healthcare
The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.
Fri 19 Mar 2021
Kantify announces its new drug discovery technology
Kantify announces ZeptoNet, its new Virtual screening technology of small molecules
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.